Drug pricing

News

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on blockbuster immunology drug Enbrel.

News

Pharma trade body EFPIA says access to new medicines is worsening across Europe, as it makes the socioeconomic case for spending more on novel drugs.

News

A Section 301 probe by the US Trade Representative into Germany's medicine pricing and reimbursement policies raises the threat of punitive tariffs.

News

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

News

EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.

News

SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.